China Non-steroidal Anti-inflammatory Drugs Market (2025-2031) | Forecast, Analysis, Size & Revenue, Share, Industry, Value, Competitive Landscape, Companies, Trends, Growth, Outlook, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F

3.3 China Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle

3.4 China Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces

3.5 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.6 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic inflammatory diseases in China

4.2.2 Growing aging population leading to higher demand for pain management medications

4.2.3 Rising awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) among Chinese consumers

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval and marketing of NSAIDs in China

4.3.2 Potential side effects and risks associated with long-term use of NSAIDs

4.3.3 Competition from alternative pain management therapies such as acupuncture and traditional Chinese medicine

6.1 China Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration

6.1.1 Overview and Analysis

6.1.2 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F

6.1.3 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.1.4 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.1.5 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F

6.2 China Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F

6.2.3 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F

6.2.4 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F

6.2.5 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 China Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.3.3 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3.4 China Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 China Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries

7.2 China Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries

8.1 Prescription rate of NSAIDs by healthcare providers in China

8.2 Patient adherence to NSAID treatment regimens

8.3 Number of clinical trials studying the efficacy and safety of NSAIDs in Chinese population

9.1 China Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.2 China Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 China Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 China Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024

10.2 China Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters